FDA evaluating prostate cancer risk with Stalevo - MPR
Links shared publicly online about this topic.
- 1,274total visits
FDA evaluating prostate cancer risk with Stalevo - MPR
empr.com —
View full resource at empr.com
Tags: Cancer, Prostate Cancer, Prostate, Healthcare, Clinical Trial, Men's Health, FDA, Novartis
Most Recently Shared on March 31, 2010 at 9:07 pm By:
MPR News: FDA evaluating prostate cancer risk with Stalevo: The FDA has notified healthcare professionals and pati... http://bit.ly/aGHNzl
Living With Parkinson's - News in Context and Position Papers - News In Context The Michael J. Fox Foundation - News in Context: PD and Cancer Risk
michaeljfox.org — “On March 31, 2010, the FDA announced it was investigating the Parkinson’s disease drug Stalevo for a possible association with prostate cancer. The announcement followed findings from a large trial, STRIDE-PD, which found an increased risk of p...” View full resource at michaeljfox.org
Most Recently Shared on April 20, 2010 at 3:51 pm By:
michaeljfox.org Health Organization
Heard about the FDA investigation of Stalevo? Read MJFF's interview with Dr. Bressman to find out what it really means http://bit.ly/c5jT8m
FDA evaluating cancer link in Parkinson's drug | Reuters
reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at reuters.com
Most Recently Shared on April 1, 2010 at 8:54 pm By:
FDA evaluating cancer link in Parkinson's drug. http://bit.ly/90Fnls
FDA evaluating cancer link in Parkinson's drug | Reuters
reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at reuters.com
Most Recently Shared on April 1, 2010 at 2:01 am By:
Hisham Rana, MD Doctor and Physician
FDA evaluating prostate cancer link to Parkinson's drug Stalevo (carbidopa, levodopa, entacapone) http://bit.ly/b6CN8A - #health
Parkinson's drug may cause prostate cancer - UPI.com
upi.com — “The U.S. Food and Drug Administration says it's evaluating a clinical trial that suggests taking Stalevo may place people at risk of getting prostate cancer.” View full resource at upi.com
Most Recently Shared on March 31, 2010 at 11:13 pm By:
Parkinson's drug may cause prostate cancer http://bit.ly/adq6Ha
FDA evaluating cancer link in Parkinson's drug | Reuters
feeds.reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at feeds.reuters.com
Most Recently Shared on March 31, 2010 at 9:21 pm By:
FDA evaluating cancer link in Parkinson's drug http://link.reuters.com/bat95j
FDA evaluating cancer link in Parkinson's drug | Reuters
feeds.reuters.com — “NEW YORK (Reuters) - The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. Data” View full resource at feeds.reuters.com
Most Recently Shared on March 31, 2010 at 9:00 pm By:
HealthIT Policy Health News and Health IT
FDA evaluating cancer link in Parkinson's drug: NEW YORK (Reuters) - The U.S. Food and Drug Administration is eval... http://bit.ly/aaHNP9
FDA evaluating prostate cancer risk with Stalevo - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals and patients that it is evaluating data from the long-term STRIDE-PD clinical trial, that may suggest that patients taking Stalevo (carbidopa/levodopa/entacapone, from Novartis) may be at an increased risk for developing prostate cancer.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 31, 2010 at 8:46 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
FDA evaluating prostate cancer risk with Stalevo http://goo.gl/fb/FiISG
Advertisement
